Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
Pharmacology, Toxicology and Pharmaceutical Science
2
4%
Other
3
5%
Unknown
24
44%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2024.
All research outputs
#8,385,906
of 26,493,631 outputs
Outputs from Frontiers in endocrinology
#2,563
of 13,611 outputs
Outputs of similar age
#177,046
of 530,706 outputs
Outputs of similar age from Frontiers in endocrinology
#122
of 561 outputs
Altmetric has tracked 26,493,631 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 13,611 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,706 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 561 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.
